Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


Werewolf Therapeutics
1030 Massachusetts Avenue, Suite 210
Cambridge, MA 02138
Phone: 617-952-0555
https://werewolftx.com/

Werewolf Therapeutics is an oncology biotherapeutics company advancing a pipeline of next-generation, transformative cancer treatments designed to focus the body's immune response to selectively target cancer. Werewolf's proprietary PREDATOR™ protein engineering platform combines a variety of approaches to actively silence the drug while in systemic circulation, optimize its pharmacokinetic profile, and rapidly and efficiently transform into the fully active state upon reaching the tumor microenvironment for maximum therapeutic potential. Werewolf is creating a new era of tumor-selective, systemically delivered drugs with the potential to deliver more effective, less toxic treatments for people with cancer.

Key Contact
NameTitleE-Mail
Dan HicklinCEOdHicklin@werewolftx.com


Funding Events
DateAmountTypeInvestors
11/20/19$56,000,000Series A Arkin Bio Ventures
DC Investment Partners
Longwood Fund  
MPM Capital  
Taiho Ventures
UPMC Enterprises
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.